| Literature DB >> 26585638 |
Jennifer R Mertens1, Felicia W Chi2, Constance M Weisner3,4, Derek D Satre5,6, Thekla B Ross7, Steve Allen8, David Pating9, Cynthia I Campbell10, Yun Wendy Lu11, Stacy A Sterling12.
Abstract
BACKGROUND: Unhealthy alcohol use is a major contributor to the global burden of disease and injury. The US Preventive Services Task Force has recommended alcohol screening and intervention in general medical settings since 2004. Yet less than one in six US adults report health care professionals discussing alcohol with them. Little is known about methods for increasing implementation; different staffing models may be related to implementation effectiveness. This implementation trial compared delivery of alcohol screening, brief intervention and referral to specialty treatment (SBIRT) by physicians versus non-physician providers receiving training, technical assistance, and feedback reports.Entities:
Mesh:
Year: 2015 PMID: 26585638 PMCID: PMC4653951 DOI: 10.1186/s13722-015-0047-0
Source DB: PubMed Journal: Addict Sci Clin Pract ISSN: 1940-0632
Fig. 1Flow diagram of participating clinics, physicians and patients through phases of the trial
Screening rates by treatment arms in first year
| Average unique visits per month | Average screens per month | Average % screened | p value | Best month N screened | Best month % screened | p value | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCP | NPP & MA | Control | PCP | NPP & MA | Control | PCP | NPP & MA | Control | PCP | NPP &MA | Control | PCP | NPP & MA | Control | |||
| Medical center | |||||||||||||||||
| 1 | 1464 | 2797 | 2928 | 41 | 1107 | 148 | 2.80 | 39.56 | 5.07 | a,b,c | 161 | 1505 | 391 | 11.47 | 46.88 | 13.81 | a,b’,c |
| 2 | 1088 | 1424 | 1392 | 51 | 824 | 24 | 4.67 | 57.84 | 1.73 | a,b,c | 102 | 1039 | 68 | 9.31 | 66.65 | 5.00 | a, b,c |
| 3 | 925 | 748 | 1779 | 58 | 197 | 403 | 6.28 | 26.33 | 22.64 | a,b,c | 126 | 467 | 697 | 13.15 | 55.12 | 35.49 | a,b,c |
| 4 | 4318 | 4536 | 1639 | 552 | 2962 | 4 | 12.77 | 65.29 | 0.26 | a,b,c | 861 | 3681 | 23 | 19.79 | 71.71 | 1.18 | a,b,c |
| 5 | 1569 | 884 | 1717 | 509 | 411 | 107 | 32.43 | 46.51 | 6.22 | a,b,c | 635 | 723 | 235 | 37.90 | 64.21 | 14.61 | a,b,c |
| 6 | 3124 | 7668 | 3372 | 177 | 3705 | 29 | 5.68 | 48.32 | 0.85 | a,b,c | 332 | 5644 | 63 | 10.15 | 74.68 | 2.02 | a,b,c |
| 7 | 3336 | 2452 | 1898 | 339 | 225 | 6 | 10.17 | 9.16 | 0.33 | a,b,c | 980 | 636 | 25 | 26.04 | 29.42 | 1.49 | a,b,c’ |
| 8 | 3866 | 4067 | 5686 | 565 | 2778 | 167 | 14.62 | 68.32 | 2.94 | a,b,c | 964 | 3355 | 350 | 28.41 | 75.48 | 5.81 | a,b,c |
| 9 | 5111 | 955 | 2531 | 405 | 142 | 8 | 7.92 | 14.86 | 0.33 | a,b,c | 608 | 254 | 41 | 12.36 | 31.59 | 1.76 | a,b,c |
| 10 | 4297 | 5034 | 6031 | 345 | 2827 | 79 | 8.03 | 56.17 | 1.32 | a,b,c | 637 | 3938 | 195 | 15.07 | 73.16 | 3.39 | a,b,c |
| 11 | 6636 | 3715 | 3125 | 239 | 2223 | 138 | 3.60 | 59.85 | 4.41 | a,b,c | 355 | 2586 | 443 | 5.04 | 70.78 | 15.08 | a,b,c |
| All | 35,519 | 34,167 | 31935 | 3280 | 17397 | 1113 | 9.23 | 50.92 | 3.49 | a,b,c | 3,729 | 20,445 | 1918 | 10.68 | 60.07 | 6.04 | a,b,c |
Differences in screening rates between each of the two intervention arms vs. Control arm as well as between the two intervention arms were examined by hand calculating z statistics for comparisons of two proportions
ap<0.0001, NPP & MA vs. Control; bp<0.0001, PCP vs. Control; b’p<0.05, PCP vs. Control; cp<0.0001, NPP & MA vs. PCP; c’p<0.01, NPP & MA vs. PCP
Fig. 2Average screening rates by month for NPP and MA arm, PCP arm and control arm
“Unhealthy drinkers” who received brief interventions or referral to treatment (BI/RT) by treatment arm
| PCP | NPP & MA | Control | p values2 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N screened positive | N received BI/RT | % | N screened positive | N received BI/RT | % | N screened positive | N received BI/RT | % | ||
| Medical center | ||||||||||
| 1 | 90 | 51 | 56.67 | 1916 | 47 | 2.45 | 185 | 1 | 0.54 | b, c |
| 2 | 129 | 16 | 12.40 | 1849 | 24 | 1.30 | 41 | 1 | 2.44 | b’’’, c |
| 3 | 51 | 8 | 15.69 | 123 | 5 | 4.07 | 216 | 3 | 1.39 | b’, c’’ |
| 4 | 241 | 141 | 58.51 | 1829 | 96 | 5.25 | 6 | 0 | 0.00 | b’’, c |
| 5 | 145 | 17 | 11.72 | 229 | 23 | 10.04 | 142 | 3 | 2.11 | a’, b’’ |
| 6 | 246 | 120 | 48.78 | 2114 | 69 | 3.26 | 19 | 1 | 5.26 | b’, c |
| 7 | 394 | 200 | 50.76 | 172 | 9 | 5.23 | 26 | 0 | 0.00 | b, c |
| 8 | 503 | 153 | 30.42 | 1776 | 47 | 2.65 | 137 | 9 | 6.57 | a’’, b, c |
| 9 | 306 | 15 | 4.90 | 54 | 16 | 29.63 | 9 | 0 | 0.00 | a’’’, c |
| 10 | 697 | 545 | 78.19 | 4260 | 140 | 3.29 | 175 | 7 | 4.00 | b, c |
| 11 | 306 | 115 | 37.58 | 1259 | 55 | 4.37 | 176 | 5 | 2.84 | b, c |
| All | 3108 | 1381 | 44.43 | 15581 | 531 | 3.41 | 1132 | 30 | 2.65 | b, c |
1Chi-square tests were used to compare the proportions of patients screened between each of the two intervention arms vs. control as well as between the two intervention arms
2a: p<0.0001, NPP & MA vs. Control. a’ p<0.01, NPP & MA vs. Control. a’’: p<0.05, NPP & MA vs. Control. a’’’: p<0.10, NPP & MA vs. Control. b: p<0.0001, PCP vs. Control. b’: p<0.001, PCP vs. Control. b’’: p<0.01, PCP vs. Control. b’’’: p<0.10, PCP vs. Control. c: p<0.0001, NPP & MA vs. PCP. c’: p<0.01, NPP & MA vs. PCP. c’’: p<0.05, NPP & MA vs. PCP
Patient-, physician- and system-level factors associated with delivery of screening by treatment arm
| PCP Arm | NPP & MA Arm | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Coefficient value | Std. err. | OR | 95% CI | p value | Coefficient value | Std. err. | OR | 95% CI | p value | |
|
| ||||||||||
| Age | ||||||||||
| 18–24 vs. ≥60 | −0.1018 | 0.0430 |
|
|
| −0.1726 | 0.0656 |
|
|
|
| 25–44 vs. ≥60 | −0.1582 | 0.0303 |
|
|
| −0.1329 | 0.0426 |
|
|
|
| 45–59 vs. ≥60 | −0.1074 | 0.0280 |
|
|
| −0.1319 | 0.0408 |
|
|
|
| | ||||||||||
| Female vs. Male | −0.2447 | 0.0217 |
|
|
| −0.2008 | 0.0305 |
|
|
|
| | ||||||||||
| Yes vs. no | 0.1231 | 0.0269 |
|
|
| 0.2436 | 0.0383 |
|
|
|
| | ||||||||||
| Yes vs. no | 0.1934 | 0.0243 |
|
|
| 0.3407 | 0.0345 |
|
|
|
|
| ||||||||||
| Age | ||||||||||
| (per 1 year increase) | −0.2183 | 0.0034 |
|
|
| |||||
| Gender | ||||||||||
| Female vs. male | 1.1647 | 0.0247 |
|
|
| |||||
| Race/ethnicity | ||||||||||
| Non-white vs. white | 1.4355 | 0.0263 |
|
|
| |||||
| Years of services at the health plan | ||||||||||
| (per 1 year increase) | 0.2587 | 0.0032 |
|
|
| |||||
| Specialty | ||||||||||
| Non-internal medicine vs. internal medicine | 3.0877 | 0.0366 |
|
|
| |||||
|
| ||||||||||
| Colocation of AOD and primary care departments | ||||||||||
| Yes vs. no | −2.3244 | 0.0689 |
|
|
| −0.4432 | 0.2274 |
|
|
|
| MA/PCP ratio at the clinic | −0.4393 | 0.0493 |
|
|
| 3.0850 | 0.0748 |
|
|
|
| Ave. visit time | 0.3606 | 0.0097 |
|
|
| 0.1379 | 0.0104 |
|
|
|
| Number of PCPs trained at the clinic | −0.0387 | 0.0047 |
|
|
| |||||
A three-level multivariate logistic model adjusting for clustering effects within physician and clinic was run for each of the two intervention arms
PCP primary care physicians, NPP non-physician providers, MA medical assistants, AOD alcohol and other drug
Patient-, physician- and system-level factors associated with delivery of BI/RT by treatment arm
| PCP Arm | NPP & MA Arm | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Coefficient value | Std. err. | OR | 95% CI | p value | Coefficient value | Std. err. | OR | 95% CI | p value | |
|
| ||||||||||
| Age | ||||||||||
| 18–24 vs. ≥60 | 0.2127 | 0.2119 | 1.24 | (0.82, 1.87) | 0.315 | 0.3589 | 0.2019 | 1.43 | (0.96, 2.13) | 0.075 |
| 25–44 vs. ≥60 | −0.1290 | 0.1755 | 0.88 | (0.62, 1.24) | 0.462 | 0.2557 | 0.1632 | 1.29 | (0.94, 1.78) | 0.117 |
| 45–59 vs. ≥60 | −0.1571 | 0.1730 | 0.85 | (0.61, 1.20) | 0.364 | 0.5254 | 0.1615 |
|
|
|
| Gender | ||||||||||
| Female vs. Male | −0.5081 | 0.1166 |
|
|
| −0.4701 | 0.1067 |
|
|
|
| Comorbid psychiatric conditions | ||||||||||
| Yes vs. no | 0.1489 | 0.1403 | 1.16 | (0.88, 1.53) | 0.289 | 0.2391 | 0.1121 |
|
|
|
| Chronic diseases | ||||||||||
| Yes vs. no | −0.0359 | 0.1165 | 0.96 | (0.77, 1.21) | 0.758 | 0.2444 | 0.0995 |
|
|
|
|
| ||||||||||
| Age | ||||||||||
| (per 1 year increase) | −0.0608 | 0.0161 |
|
|
| |||||
| Gender | ||||||||||
| Female vs. male | 0.2221 | 0.1932 | 1.25 | (0.86, 1.82) | 0.250 | |||||
| Race/ethnicity | ||||||||||
| Non-white vs. white | −0.5904 | 0.1599 |
|
|
| |||||
| Years of services at the health plan | ||||||||||
| (per 1 year increase) | 0.0614 | 0.0152 |
|
|
| |||||
| Specialty | ||||||||||
| Non-internal medicine vs. internal medicine | −0.2045 | 0.1932 | 0.82 | (0.56, 1.19) | 0.290 | |||||
|
| ||||||||||
| Colocation of AOD and primary care departments | ||||||||||
| Yes vs. no | −0.1525 | 0.5258 | 0.86 | (0.31, 2.41) | 0.772 | 0.6106 | 0.4493 | 1.84 | (0.76, 4.44) | 0.174 |
| MA/PCP ratio at the clinic | −3.1177 | 0.3265 |
|
|
| −0.4583 | 0.3325 | 0.63 | (0.33, 1.21) | 0.168 |
| Ave. visit time | 0.3111 | 0.0546 |
|
|
| 0.0106 | 0.0529 | 1.01 | (0.91, 1.12) | 0.841 |
| Number of PCPs trained at the clinic | −0.1695 | 0.0360 |
|
|
| |||||
A three-level multivariate logistic model adjusting for clustering effects within physician and clinic was run for each of the two intervention arms
BI/RT brief intervention or referral to treatment, PCP primary care physicians, NPP non-physician providers, MA medical assistants, AOD alcohol and other drug